We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
+7.94%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.28%
AUM
$6.82B
AUM Growth
+$400M
Cap. Flow
-$64.1M
Cap. Flow %
-0.94%
Top 10 Hldgs %
17.87%
Holding
394
New
21
Increased
124
Reduced
197
Closed
10

Top Sells

Rank Stock Value
1
BCR
CR Bard Inc.
BCR
+$62.1M
2
CVS icon
CVS Health
CVS
+$18M
3
ACH
Accendra Health
ACH
+$14.8M
4
UI icon
Ubiquiti
UI
+$13.1M
5
EGBN icon
Eagle Bancorp
EGBN
+$11.4M

Sector Composition

Rank Sector Weight
1 Financials 19.36%
2 Healthcare 15.63%
3 Technology 15.4%
4 Industrials 13.63%
5 Consumer Discretionary 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APAM icon
151
Artisan Partners
APAM
$2.79B
$13.3M 0.2%
337,515
-10,945
-3% -$406K
SBNY
152
DELISTED
Signature Bank
SBNY
$13.2M 0.19%
96,259
+972
+1% +$128K
FET icon
153
Forum Energy Technologies
FET
$654M
$13.2M 0.19%
42,318
-1,820
-4% -$518K
JLL icon
154
Jones Lang LaSalle
JLL
$15.1B
$13.1M 0.19%
88,117
-4,770
-5% -$674K
AVY icon
155
Avery Dennison
AVY
$12.3B
$12.9M 0.19%
112,401
-3,320
-3% -$359K
LKFN icon
156
Lakeland Financial Corp
LKFN
$1.52B
$12.7M 0.19%
262,922
-6,943
-3% -$340K
DEO icon
157
Diageo
DEO
$46.2B
$12.7M 0.19%
86,741
-210
-0.2% -$28.9K
TNC icon
158
Tennant Co
TNC
$1.5B
$12.6M 0.18%
173,425
-89,485
-34% -$5.97M
SAM icon
159
Boston Beer
SAM
$1.88B
$12.5M 0.18%
65,497
-764
-1% -$136K
TMP icon
160
Tompkins Financial
TMP
$1.45B
$12.3M 0.18%
151,436
-4,306
-3% -$366K
DOX icon
161
Amdocs
DOX
$5.53B
$12.2M 0.18%
186,381
+3,067
+2% +$199K
AFG icon
162
American Financial Group
AFG
$11.9B
$12M 0.18%
110,163
+2,111
+2% +$222K
SEIC icon
163
SEI Investments
SEIC
$11.9B
$11.9M 0.17%
165,948
+1,774
+1% +$119K
RVTY icon
164
Revvity
RVTY
$12.3B
$11.5M 0.17%
157,250
+23,071
+17% +$1.66M
KWR icon
165
Quaker Houghton
KWR
$2.63B
$11.5M 0.17%
76,097
-1,718
-2% -$266K
RPM icon
166
RPM International
RPM
$13.7B
$11.4M 0.17%
217,456
+14,182
+7% +$742K
SAFM
167
DELISTED
Sanderson Farms Inc
SAFM
$11.3M 0.17%
81,692
-33,717
-29% -$5.21M
INDB icon
168
Independent Bank
INDB
$4.05B
$11.1M 0.16%
159,451
-78,241
-33% -$5.6M
WAB icon
169
Wabtec
WAB
$51.1B
$11.1M 0.16%
136,096
+3,205
+2% +$245K
LAMR icon
170
Lamar Advertising Co
LAMR
$16.2B
$11M 0.16%
148,784
-1,408
-0.9% -$103K
COO icon
171
Cooper Companies
COO
$13.7B
$10.9M 0.16%
200,944
+8,060
+4% +$471K
APA icon
172
APA Corp
APA
$12.8B
$10.9M 0.16%
259,039
-6,865
-3% -$289K
SLB icon
173
SLB Ltd
SLB
$77.8B
$10.8M 0.16%
160,969
-1,970
-1% -$128K
ANSS
174
DELISTED
Ansys
ANSS
$10.8M 0.16%
73,447
+986
+1% +$140K
ILG
175
DELISTED
ILG, Inc Common Stock
ILG
$10.8M 0.16%
380,572
-287,777
-43% -$8.3M

Similar funds

Boston Trust Walden's Q4 2017 Portfolio in Review

As of Q4 2017, Boston Trust Walden held 394 positions worth $6.82B, up 6.2% from $6.42B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Boston Trust Walden's Q4 2017 filing shows 21 new, 124 increased, 197 reduced and 10 closed positions. Its largest new stake was Charles River Laboratories: 122,536 shares worth $13.4M. The largest sale was CR Bard Inc., an estimated $62.1M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Technology.

  • Boston Trust Walden's largest Q4 2017 buy was Charles River Laboratories: 122,536 shares worth $13.4M.
  • Boston Trust Walden added most to Becton Dickinson in Q4 2017, an estimated $14.8M increase.
  • Boston Trust Walden's biggest Q4 2017 reduction was CVS Health, cutting an estimated $18M.
  • Boston Trust Walden fully exited CR Bard Inc. in Q4 2017, selling an estimated $62.1M.
  • Boston Trust Walden's ten largest holdings make up 18% of its $6.82B portfolio in Q4 2017.
  • Boston Trust Walden opened 21 new positions and closed 10 in Q4 2017.
  • Boston Trust Walden's portfolio value rose 6.2% quarter-over-quarter to $6.82B.

Based on Boston Trust Walden's 13F filing for Q4 2017, filed 29 Jan 2018.